Heparanase facilitates cell adhesion and spreading by clustering of cell surface heparan sulfate proteoglycans

PLoS ONE

Volumn 3, Issue 6, 2008, Pages

  Levy Adam, Flonia ^a   Feld, Sari ^a   Suss Toby, Edith ^a   Vlodavsky, Israel ^a   Ilan, Neta ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; HEPARANASE; HEPARIN; LYSINE; PEPTIDE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; PROTEOHEPARAN SULFATE; RAC1 PROTEIN; SYNDECAN 1; SYNDECAN 4; BETA GLUCURONIDASE; OLIGOPEPTIDE; SYNDECAN;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL MEMBRANE; CELL SPREADING; CELL STIMULATION; CELL STRUCTURE; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BINDING; ENZYME INHIBITION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN AGGREGATION; PROTEIN DOMAIN; PROTEIN INTERACTION; RAT; AMINO ACID SEQUENCE; CELL MOTION; CHEMISTRY; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; TUMOR CELL LINE;

AMINO ACID SEQUENCE; CELL ADHESION; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; GLUCURONIDASE; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; IMMUNOHISTOCHEMISTRY; OLIGOPEPTIDES; PROTEIN BINDING; SYNDECANS;

EID: 48649093683     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002319     Document Type: Article

References (60)

1. Selleck SB (2000) Proteoglycans and pattern formation: sugar biochemistry meets developmental genetics. Trends Genet 16: 206-212.
2. Kjellen L, Lindahl U (1991) Proteoglycans: structures and interactions. Annu Rev Biochem 60:443-475.
3. Jackson RL, Busch SJ, Cardin AD (1991) Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev 71: 481-539.
4. Sasisekharan R, Shriver Z, Venkataraman G, Narayanasami U (2002) Roles of heparan-sulphate glycosaminoglycans in cancer. Nat Rev Cancer 2: 521-528.
5. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, et al. (1999) Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68: 729-777.
6. Hacker U, Nybakken K, Perrimon N (2005) Heparan sulphate proteoglycans: the sweet side of development. Nature Reviews Molecular Cell Biology 6: 530-541.
7. Timpl R, Brown JC (1996) Supramolecular assembly of basement membranes. Bioessays 18: 123-132.
8. Capita I, Linhardt RJ (2002) Heparin-protein interactions. Angew Chem Int Ed Engl 41: 391-412.
9. Cardin AD, Weintraub HJ (1989) Molecular modeling or protein-glycosaminoglycan interactions. Arteriosclerosis 9: 21-32.
10. Belting M (2003) Heparan sulfate proteoglycan as a plasma membrane carrier. Trends Biochem Sci 28: 145-151.
11. Vlodavsky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaeli R, et al. (1987) Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA 84: 2292-2296.
12. Bashkin P, Doctrow S, Klagsbrun M, Svahn CM, Folkman J, et al. (1989) Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 28: 1737-1743.
13. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, et al. (1988) A heparin-binding angiogenic protein-basic fibroblast growth factor-is stored within basement membrane. Am J Pathol 130: 393-100.
14. Vlodavsky I, Miao HQ, Medalion B, Danagher P, Ron D (1996) Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev 15: 177-186.
15. Vlodavsky I, Bar-Shavit R, Ishai-Michaeli R, Bashkin P, Fuks Z (1991) Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends Biochem Sci 16: 268-271.
16. Page-McCaw A, Ewald AJ, Werb Z (2007) Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mot Cell Biol 8: 221-233.
17. Werb Z (1997) ECM and cell surface proteolysis: regulating cellular ecology. Cell 91: 439-442.
18. McKenzie EA (2007) Heparanase: a target for drug discovery in cancer and inflammation. Br J Pharmacol 151: 1-14.
19. Bar-Ner M, Kramer MD, Schirrmacher V, Ishai-Michaeli R, Fuks Z, et al. (1985) Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells. Int J Cancer 35: 483-491.
20. Nakajima M, Irimura T, DiFerrante D, DiFerrante N, Nicolson GL (1983) Heparan sulfate degradation: relation to tumor invasion and metastatic properties of Mouse B 16 Melanoma sublines. Science (Wash DC) 220: 611-613.
21. Vlodavsky I, Fuks Z, Bar-Ner M, Ariav Y, Schirrmacher V (1983) Lymphoma cells mediated degradation or sulfated proteoglycaris in the subendothelial extracellular matrix: relation to tumor cell metastasis. Cancer Res 43: 2704-2711.
22. Ilan N, Elkin M, Vlodavsky I (2006) Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol 38: 2018-2039.
23. Miao HQ, Liu H, Navarro E, Kussie P, Zhu Z (2006) Development of heparanase inhibitors for anti-cancer therapy. Curr Med Chem 13: 2101-2111.
24. Sanderson RD, Yang Y, Suva LJ, Kelly T (2001) Heparan sulfate proteoglycans and heparanase-partners in osteolytic tumor growth and metastasis. Matrix Biol 23: 341-352.
25. Vlodavsky I, Abboud-Jarrous G, Elkin M, Naggi A, Casu B, Sasisekharan R, et al. (2006) The impact of heparanese and heparin on cancer metastasis and angiogenesis. Pathophysiol Haemost Thromb 35: 116-127.
26. Zetser A, Bashenko Y, Miao H-Q, Vlodavsky I, Ilan N (2003) Heparanase affects adhesive and tumorigenic potential of human glioma cells. Cancer Res 63: 7733-7741.
27. Goldshmidt O, Zcharia E, Cohen M, Aingorn H, Cohen I, et al. (2003) Heparanase mediates cell adhesion independent of its enzymatic activity. FASEB J 17: 1015-1025.
28. Sotnikov I, Hershkoviz R, Grabovsky V, Ilan N, Cahalon L, et al. (2004) Enzymatically quiescent heparanase augments T cell interactions with VCAM-1 and extracellular matrix components under versatile dynamic contexts. J Immumol 172: 5185-5193.
29. Levy-Adam F, Abboud-Jarrous G, Guerrini M, Beccati D, Vlodavsky I, et al. (2005) Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase.J Biol Chem 280: 20457-20466.
30. Beauvais DM, Rapraeger AC (2004) Syndecans in tumor cell adhesion and signaling. Reprod Biol Endocrinol 2: 3.
31. Couchman JR (2003) Syndecans: proteoglycan regulators of cell-surface microdomains? Nat Rev Mol Cell Biol 4: 926-937.
32. Saoncella S, Echtermeyer F, Denhez F, Nowlen JK, Mosher DF, et al. (1999) Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers. Proc Natl Acad Sci USA 96: 2805-2810.
33. Tkachenko E, Rhodes JM, Simons M (2005) Syndecans: new kids on the signaling block. Circ Res 96: 488-500
34. Woods A, Couchman JR (2001) Syndecan-4 and focal adhesion function. Curr Opin Cell Biol 13: 578-583.
35. Bass MD, Roach KA, Morgan MR, Mostafavi-Pour Z, Schoen T, et al. (2007) Syndecan-4-dependent Racl regulation determines directional migration in response to the extracellular matrix. J Cell Biol 177: 527-538.
36. Dovas A, Yoneda A, Couchman JR (2006) PKCbeta-dependent activation of RhoA by syndecan-4 during focal adhesion formation. J Cell Sci 119: 2837-2846.
37. Tkachenko E, Elfenbein A, Tirziu D, Simons M (2006) Syndecan-4 clustering induces cell migration in a PDZ-dependent manner. Circ Res 98: 1398-1404.
38. Woods A, McCarthy JB, Furcht LT, Couchman JR (1993) A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation. Mol Biol Cell 4: 605-613.
39. Gingis-Velitski S, Zetser A, Kaplan V, Ben-Zaken O, Cohen E, et al. (2004) Heparanase Uptake Is Mediated by Cell Membrane Heparan Sulfate Proteoglycans. J Biol Chem 279: 44084-14092.
40. Nadav L, Katz BZ, Baron S, Cohen N, Naparstek E, Geiger B (2006) The generation and regulation of functional diversity or malignant plasma cells. Cancer Res 66: 8608-8616.
41. Hulett MD, Hornby JR, Ohms SJ, Zuegg J, Freeman C, et al. (2000) Identification of active-site residues of the pro-metastatic endoglycosidase heparanase. Biochemistry 39: 15659-15667.
42. Zetser A, Bashenko Y, Edovitsky E, Levy-Adam F, Vlodavsky I, et al. (2006) Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer Res 66: 1455-1463.
43. Shafat I, Vlodavsky I, Ilan N (2006) Characterization or mechanisms involved in secretion of active heparanase. J Biol Chem 281: 23804-23811.
44. Zetser A, Levy-Adam F, Kaplan V, Gingis-Velitski S, Bashenko Y, et al. (2004) Processing and activation of latent heparanase occurs in lysosomes. J Cell Sci 117: 2249-2258.
45. Levy-Adam F, Miao HQ, Heinrikson RL, Vlodavsky I, Ilan N (2003) Heterodimer formation is essential for heparanase enzymatic activity. Biochem Biophys Res Commun 308: 885-891.
46. Vreys V, Delande N, Zhang Z, Coomans C, Roebroek A, et al. (2005) Cellular Uptake of Mammalian Heparanase Precursor Involves Low Density Lipoprotein Receptor-related Proteins, Mannose 6-Phosphate Receptors, and Heparan Sulfate Proteoglycans. J Biol Chem 280: 33141-33148.
47. Nadir Y, Brenner B, Zetser A, Ilan N, Shafat I, et al. (2006) Heparanase induces tissue factor expression in vascular endothelial and cancer cells. J Thromb Haemost 4: 2443-2451.
48. Hynes R (1985) Molecular biology of fibronectin. Annu Rev Cell Biol 1: 67-90.
49. Barkalow FJ, Schwarzbauer JE (1991) Localization of the major heparin-binding site in fibronectin. J Biol Chem 266: 7812-7818.
50. Burridge K, Wennerberg K (2004) Rho and Rae take center stage. Cell 116: 167-179.
51. del Pozo MA, Alderson NB, Kiosses WB, Chiang HH, Anderson RG, et al. (2004) Integrins regulate Rac targeting by internalization of membrane domains. Science 303: 839-842.
52. Gingis-Velitski S, Zetser A, Flugelman MY, Vlodavsky I, Ilan N (2004) Heparanase induces endothelial cell migration via protein kinase B/Akt activation. J Biol Chem 279: 23536-23541.
53. Verrecchio A, Germann MW, Schick BP, Kung B, Twardowski T, San Antonio JD (2000) Design of peptides with high affinities for heparin and endothelial cell proteoglycans. J Biol Chem 275: 7701-7707.
54. Simons M, Horowitz A (2001) Syndecan-4-mediated signalling. Cell Signal 13: 855-862.
55. Lin YL, Lei YT, Hong CJ, Hsuch YP (2007) Syndecan-2 induces filopodia and dendritic spine formation via the neurofibromin-PKA-Ena/VASP pathway. J Cell Biol 177: 829-841.
56. Sanderson RD, Yang Y, Kelly T, Macleod V, Dai Y, et al. (2005) Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: Growth regulation and the prospect or new cancer therapies. J Cell Biochem 96: 897-905.
57. Yang Y, Macleod V, Bendre M, Huang Y, Theus AM, et al. (2005) Heparanase promotes the spontaneous metastasis of myeloma cells to bone. Blood 105: 1303-1309.
58. Yang Y, Macleod V, Dai Y, Khotskaya-Sample Y, Shriver Z, et al. (2007) The syndecan-1 heparan sulfate protroglycan is a viable target for mycloma therapy. Blood 110: 2041-2048.
59. Yang Y, Macleod V, Miao HQ Theus A, Zhan F, et al. (2007) Heparanase enhances syndecan-I shedding: a novel mechanism for stimulation of tumor growth and metastasis. J Biol Chem 282: 13326-13333.
60. Okawa T, Naomoto Y, Nobuhisa T, Takaoka M, Motoki T, Shirakawa Y, et al. (2005) Heparanase is involved in angiogenesis in esophageal cancer through induction of cyclooxygenase-2. Clin Cancer Res 11: 7995-8005.